Gastric (GC) and gastro-oesophageal (GOJC) adenocarcinomas are often considered as a
single entity, even though differences exist in epidemiology, clinical presentation, molecular …

The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for
Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting …

Background: For the curative treatment of gastric cancer, several neoadjuvant, and adjuvant
treatment-regimens are available which have shown to improve overall survival. No …

Standard adjuvant treatment for locally advanced gastric cancer (LAGC) is regionally
different. Whereas perioperative chemotherapy is the standard in Western populations, D2 …

The UK MAGIC trial published in 2006 was the first RCT to identify improved long-term
survival rates using preoperative chemotherapy for resectable gastric or gastroesophageal …

Although advances in medical treatment for gastric cancer (GC) have been made, surgery
remains the mainstay of cure for patients with localized disease. Improvement in surgical …

Simple Summary Oesophageal (food pipe) and stomach cancers are amongst the hard-to-
treat cancers that result in significant illness and deaths around the globe. Over the last few …

Gastric cancer is the fifth most common cancer worldwide and has a high mortality rate. In
the last decades, treatment strategy has shifted from an exclusive surgical approach to a …

Gastric cancer (GC) remains a major world-wide challenge, especially in Asian countries.
Chemotherapy with 5-fluorouracil (5-FU) and cisplatin is used as the first-line treatment and …

Background Surgery plus peri-operative/adjuvant chemotherapy is the standard of care for
locally advanced GC/GEJC, though with unsatisfactory results. dMMR/MSI-high tumors have …